iStock
iStock

New App Uses Crowdsourcing to Find You an EpiPen in an Emergency

iStock
iStock

Many people at risk for severe allergic reactions to things like peanuts and bee stings carry EpiPens. These tools inject the medication epinephrine into one's bloodstream to control immune responses immediately. But exposure can turn into life-threatening situations in a flash: Without EpiPens, people could suffer anaphylactic shock in less than 15 minutes as they wait for an ambulance. Being without an EpiPen or other auto-injector can have deadly consequences.

EPIMADA, a new app created by researchers at Israel's Bar-Ilan University, is designed to save the lives of people who go into anaphylactic shock when they don't have EpiPens handy. The app uses the same type of algorithms that ride-hailing services use to match drivers and riders by location—in this case, EPIMADA matches people in distress with nearby strangers carrying EpiPens. David Schwartz, director of the university's Social Intelligence Lab and one of the app's co-creators, told The Jerusalem Post that the app currently has hundreds of users. Registered users are required to have an epinephrine prescription, and must apply (by emailing abigailk@mda.org.il) to join the community.

EPIMADA serves as a way to crowdsource medication from fellow patients who might be close by and able to help. While it may seem unlikely that people would rush to give up their own expensive life-saving tool for a stranger, EPIMADA co-creator Michal Gaziel Yablowitz, a doctoral student in the Social Intelligence Lab, explained in a press release that "preliminary research results show that allergy patients are highly motivated to give their personal EpiPen to patient-peers in immediate need."

EpiPen is easy to use, so even though fellow allergy sufferers may not have medical training, it's a relatively low-risk venture to ask them to treat a stranger the same way they'd treat themselves. The tool could be especially useful for children, who may be most likely to forget their EpiPens.

The app is currently available only in Israel, but the idea could be applicable across the world, for multiple life-threatening conditions. The researchers are collaborating on similar patient-to-patient apps elsewhere, including one in Philadelphia connecting people who carry the opioid overdose reversal medication naloxone.

nextArticle.image_alt|e
MARS Bioimaging
The World's First Full-Color 3D X-Rays Have Arrived
MARS Bioimaging
MARS Bioimaging

The days of drab black-and-white, 2D X-rays may finally be over. Now, if you want to see what your broken ankle looks like in all its full-color, 3D glory, you can do so thanks to new body-scanning technology. The machine, spotted by BGR, comes courtesy of New Zealand-based manufacturer MARS Bioimaging.

It’s called the MARS large bore spectral scanner, and it uses spectral molecular imaging (SMI) to produce images that are fully colorized and in 3D. While visually appealing, the technology isn’t just about aesthetics—it could help doctors identify issues more accurately and provide better care.

Its pixel detectors, called “Medipix” chips, allow the machine to identify colors and distinguish between materials that look the same on regular CT scans, like calcium, iodine, and gold, Buzzfeed reports. Bone, fat, and water are also differentiated by color, and it can detect details as small as a strand of hair.

“It gives you a lot more information, and that’s very useful for medical imaging. It enables you to do a lot of diagnosis you can’t do otherwise,” Phil Butler, the founder/CEO of MARS Bioimaging and a physicist at the University of Canterbury, says in a video. “When you [have] a black-and-white camera photographing a tree with its leaves, you can’t tell whether the leaves are healthy or not. But if you’ve got a color camera, you can see whether they’re healthy leaves or diseased.”

The images are even more impressive in motion. This rotating image of an ankle shows "lipid-like" materials (like cartilage and skin) in beige, and soft tissue and muscle in red.

The technology took roughly a decade to develop. However, MARS is still working on scaling up production, so it may be some time before the machine is available commercially.

[h/t BGR]

nextArticle.image_alt|e
iStock
More Studies See Links Between Alzheimer's and Herpes
iStock
iStock

Although it was discovered in 1906, Alzheimer’s disease didn’t receive significant research attention until the 1970s. In 1984, scientists identified the plaque-like buildup of amyloid beta proteins in brain tissue that causes nerve damage and can lead to symptoms like memory loss, personality changes, and physical debility.

Now, researchers are learning why amyloid beta tends to collect in brain tissue like barnacles on a ship. It might not be rallying expressly to cause damage, but to protect the brain from another invader: the herpes simplex virus.

As The Atlantic recently noted, a number of studies have strengthened the notion that amyloid beta activity is working in response to herpes, the virus that travels along nerve pathways and typically causes cold sores around the mouth (HSV-1) or genitals (HSV-2). In a study involving mice, those engineered to produce more amyloid beta were more resistant to the herpes virus than those who were not.

But when too much amyloid beta is produced to combat the virus, the proteins can affect the brain’s neurons. And while herpes tends to target specific pathways in the body that result in external sores, it’s possible that the virus might act differently in an older population that is susceptible to more widespread infection. Roughly half of adults under age 50 in the U.S. are infected with HSV-1 and 12 percent with HSV-2, which suggests that a large swath of the population could be vulnerable to Alzheimer's disease. Two other strains of the virus, HHV-6A and HHV-7, have also been found to be more common in the brains of deceased Alzheimer’s patients than in the general population.

More research will be needed to further understand the possible relationship between the two. If more findings support the theory, then it’s possible that antiviral drugs or vaccines targeting herpes might also reduce the chances of amyloid beta buildup.

[h/t Atlantic]

SECTIONS

arrow
LIVE SMARTER
More from mental floss studios